Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHC.L Regulatory News (PHC)

  • There is currently no data for PHC

Head Office Relocation,Research Facility Expansion

19 Jul 2013 07:00

RNS Number : 6779J
Plant Health Care PLC
19 July 2013
 



19 July 2013

 

PLANT HEALTH CARE PLC

 

Plant Health Care relocates head office and expands research facilities

 

Plant Health Care (AIM/CISX: PHC.L), a leading provider of naturally derived products to the agriculture industry, announces that it is relocating its headquarters from Pittsburgh, PA to Raleigh, NC. The relocation will take place during the remainder of 2013, with completion of the transition by the end of this year. 

 

The company is also significantly increasing its research activities and personnel. The research facilities have now moved from their previous location to a much-expanded office and laboratory facility in the Seattle, WA area. The new facilities are approximately four times the size of the previous location and will accommodate additional senior scientists and technicians.

 

Dr. Christopher Richards, Chairman of Plant Health Care commented on the head office relocation: "The Board and Shareholders of Plant Health Care concluded that relocating the headquarters of the company to one of the major global agriculture industry communities was in the best interests of the company. North Carolina is home to a number of leading agriculture players and offers world-class infrastructure, workforce and resources for our business."

 

Paul Schmidt, CEO of Plant Health Care commented on the research expansion: "Our recent successful placing enables us to ramp-up our research activities significantly over the next few years. The primary focus of this enhanced effort will be the continued discovery and development of the Harpin technology platform, driven by the current commercial success of Harpin alpha-beta and by very promising early results with third generation products."

 

Dr. Zhongmin Wei, Vice President and Chief Science Officer of Plant Health Care commented: "The expansion of the research investment and activities is an exciting development for Plant Health Care. We have developed a remarkable platform of technology and intellectual property and the opportunity to continue expanding and accelerating this development is extremely exciting. I have been involved in the development of Plant Health Care's technology for a long time and am thrilled with the opportunity to take this platform to the next level."

 

- ENDS-

 

About Plant Health Care, plc: Plant Health Care, plc ("PHC") is a leading provider of naturally derived products for plants and soil. The Company's ordinary shares have been quoted on the Alternative Investment Market ("AIM") of the London Stock Exchange since July 2004 and listed on the Official List of the Channel Islands Stock Exchange ("CISX") in February 2010 (ticker symbol/ mnemonic: PHC).

 

PHC's products are aimed at agriculture industries and are environmentally beneficial. Through the commercialisation of these products, PHC is capitalising on current long-term trends toward natural systems and biological products for plant care and soil and water management.

 

Further information is available at: www.planthealthcare.com or please contact:

 

 

Plant Health Care plc
 
Paul Schmidt, Chief Executive Officer
Tel: +1-412-826-5488
Stephen Weaver, Finance Director
Tel: +1-412-826-5488
 
 
Nomura Code Securities
 Tel: +44 (0) 20 7776 1200
Clare Terlouw / Chris Golden
 
 
 
Powerscourt
Tel: +44 (0) 20 7250 1446
Paul Durman / Nick Dibden / Sophie Moate
 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAGMGMNGRVGFZZ
Date   Source Headline
3rd Aug 20177:00 amRNSHolding(s) in Company
12th Jul 20174:09 pmRNSGrant of options
30th Jun 20173:30 pmRNSHolding(s) in Company
15th Jun 20177:00 amRNSDirector/PDMR Shareholding
8th Jun 20174:35 pmRNSPrice Monitoring Extension
6th Jun 20177:00 amRNSNew Technology Update
31st May 20177:00 amRNSDirector/PDMR Shareholding
26th May 20177:00 amRNSDirector/PDMR Shareholding
22nd May 20177:00 amRNSGrant of options
11th May 201712:50 pmRNSResult of AGM
27th Apr 20177:00 amRNSPublication of Annual Report and Notice of AGM
10th Apr 20177:00 amRNSResults for the Year Ended 31 December 2016
5th Apr 20174:49 pmRNSChange of Registered Office
5th Apr 20177:00 amRNSHolding(s) in Company
5th Apr 20177:00 amRNSHolding(s) in Company
20th Feb 20177:01 amRNSDirector/PDMR Shareholding
20th Feb 20177:00 amRNSBlock listing Interim Review
8th Feb 20177:00 amRNSHolding(s) in Company
18th Jan 20177:02 amRNSResearch Update
18th Jan 20177:00 amRNSTrading Statement
19th Dec 20164:40 pmRNSSecond Price Monitoring Extn
19th Dec 20164:35 pmRNSPrice Monitoring Extension
14th Dec 20164:40 pmRNSSecond Price Monitoring Extn
14th Dec 20164:35 pmRNSPrice Monitoring Extension
14th Dec 20167:00 amRNSNew Commercial Distribution Agreements
30th Nov 20167:00 amRNSDirectorate Change
17th Oct 20167:00 amRNSDirectorate Change
14th Sep 20167:00 amRNSHalf-year Report
31st Aug 20164:30 pmRNSTotal Voting Rights
23rd Aug 20162:54 pmRNSHolding(s) in Company
23rd Aug 20167:00 amRNSBlock listing Interim Review
23rd Aug 20167:00 amRNSDirector/PDMR Shareholding
22nd Aug 20163:44 pmRNSHolding(s) in Company
22nd Aug 20163:38 pmRNSHolding(s) in Company
16th Aug 201611:41 amRNSResult of General Meeting, Placing & Open Offer
29th Jul 20167:00 amRNSProposed Placing, Subscription and Open Offer
7th Jun 20167:00 amRNSProgress on New Technology Builds Momentum
23rd May 20163:09 pmRNSResult of AGM
17th May 20163:45 pmRNSChange of Registered Office Address
25th Apr 20167:00 amRNSAnnual Financial Report
8th Apr 20167:00 amRNSAnnual Financial Report
22nd Feb 20167:00 amRNSBlocklisting Interim Review
2nd Feb 20167:00 amRNSReduced Disclosure Framework
29th Jan 20167:00 amRNSTrading Statement
2nd Dec 20157:00 amRNSPHC Expands Distribution Agreement with Sym-Agro
1st Dec 20157:00 amRNSPHC notification of major interest in shares
30th Nov 20157:00 amRNSPHC and Arysta LifeScience Terminate Agreement
30th Oct 20151:21 pmRNSTotal Voting Rights
30th Sep 20153:47 pmRNSTotal Voting Rights
25th Sep 20157:00 amRNSRe Agreement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.